AAAAAA
Results:
1-19
|
Results: 19
Authors:
ZAUTRA AJ
HOFFMAN JM
MATT KS
YOCUM D
POTTER PT
CASTRO WL
ROTH S
Citation: Aj. Zautra et al., AN EXAMINATION OF INDIVIDUAL-DIFFERENCES IN THE RELATIONSHIP BETWEEN INTERPERSONAL STRESS AND DISEASE-ACTIVITY AMONG WOMEN WITH RHEUMATOID-ARTHRITIS, Arthritis care and research, 11(4), 1998, pp. 271-279
Authors:
LANE RD
PEREA S
CASTRO L
YOCUM D
DELGADO P
Citation: Rd. Lane et al., LEVEL OF EMOTIONAL AWARENESS INVERSELY ASSOCIATED WITH NONSPECIFIC SOMATIC SYMPTOMS IN FIBROMYALGIA, Psychosomatics, 39(2), 1998, pp. 197-197
Authors:
CASTRO WLR
DELGADO P
YOCUM D
PEREA SG
LANE RD
Citation: Wlr. Castro et al., FIBROMYALGIA, MENTAL-DISORDERS AND PERSONALITY STYLES, Psychosomatics, 39(2), 1998, pp. 210-211
Authors:
CASTRO W
YOCUM D
MATT K
NORDENSSON K
Citation: W. Castro et al., STRESS, HORMONES AND ARTHRITIS - THE ROLE OF PROLACTIN (PRL) AND CORTISOL (CORT) IN T-CELL REGULATION IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 41(9), 1998, pp. 791-791
Authors:
ZAUTRA AJ
HOFFMAN J
POTTER P
MATT KS
YOCUM D
CASTRO L
Citation: Aj. Zautra et al., EXAMINATION OF CHANGES IN INTERPERSONAL STRESS AS A FACTOR IN DISEASEEXACERBATIONS AMONG WOMEN WITH RHEUMATOID-ARTHRITIS, Annals of behavioral medicine, 19(3), 1997, pp. 279-286
Authors:
ORTIZ Z
TUGWELL P
YOCUM D
Citation: Z. Ortiz et al., THE DESIGN OF CLINICAL-TRIALS AIMED AT ASSESSING THE DC-ART PROPERTIES OF NEW MOLECULES IN RHEUMATOID-ARTHRITIS, Clinical and experimental rheumatology, 15(3), 1997, pp. 39-44
Authors:
ZAUTRA AJ
MATT KS
YOCUM D
Citation: Aj. Zautra et al., THE ROLE OF STRESSFUL EVENTS IN DISEASE MANIFESTATIONS AMONG RHEUMATOID-ARTHRITIS PATIENTS, Arthritis and rheumatism, 40(9), 1997, pp. 545-545
Authors:
STEIN CM
PINCUS T
YOCUM D
TUGWELL P
WELLS G
GLUCK O
KRAAG G
TORLEY H
TESSER J
MCKENDRY R
BROOKS RH
Citation: Cm. Stein et al., COMBINATION TREATMENT OF SEVERE RHEUMATOID-ARTHRITIS WITH CYCLOSPORINE AND METHOTREXATE FOR 48 WEEKS - AN OPEN-LABEL EXTENSION STUDY, Arthritis and rheumatism, 40(10), 1997, pp. 1843-1851
Authors:
SOLINGER A
PAXTON H
WEV K
YOCUM D
Citation: A. Solinger et al., IMMUNOLOGICAL MARKERS OF RESPONSE IN A MULTIDOSE PROTOCOL-7002 USING AN IMMUNOMODULATING, NONDEPLETING PRIMATIZED(TM) ANTI-CD4 MONOCLONAL-ANTIBODY IN RHEUMATOID-ARTHRITIS (RA), The FASEB journal, 10(6), 1996, pp. 1813-1813
Authors:
SOLINGER A
PAXTON H
WEY K
YOCUM D
Citation: A. Solinger et al., IMMUNOLOGICAL MARKERS OF RESPONSE IN A MULTIDOSE PROTOCOL-7002 USING AN IMMUNOMODULATING, NON-DEPLETING PRIMATIZED(TM) ANTI-CD4 MONOCLONAL-ANTIBODY IN RHEUMATOID-ARTHRITIS (RA), The FASEB journal, 10(3), 1996, pp. 2552-2552
Authors:
YOCUM D
Citation: D. Yocum, COMPARISON OF THE SAFETY, TOLERABILITY AND EFFICACY OF SANDIMMUN(R) AND SANDIMMUN NEORAL(R) IN SUBJECTS WITH SEVERE ACTIVE RA - A RANDOMIZED, DOUBLE-BLIND-STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 471-471
Authors:
YOCUM D
TORLEY H
Citation: D. Yocum et H. Torley, PLACEBO-CONTROLLED STUDIES OF THE RENAL SAFETY OF CYCLOSPORINE IN PATIENTS WITH SEVERE RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(9), 1996, pp. 472-472
Authors:
LEVY R
WEISMAN M
WIESENHUTTER C
YOCUM D
SCHNITZER T
GOLDMAN A
SCHIFF M
LEIDEN BF
SOLINGER A
MACDONALD B
LIPANI J
Citation: R. Levy et al., RESULTS OF A PLACEBO-CONTROLLED, MULTICENTER TRIAL USING A PRIMATIZEDNON-DEPLETING, ANTI-CD4 MONOCLONAL-ANTIBODY IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(9), 1996, pp. 574-574
Authors:
CAMPION GV
LEBSACK ME
LOOKABAUGH J
GORDON G
CATALANO M
BORENSTEIN D
CALDWELL J
COHEN SA
COHEN SB
FLEISCHMANN R
HELLER MD
HOWARD P
JAFFER AM
KAINE JL
KITSIS E
KOPP EJ
MORELAND LW
OHANLAN M
PRUPAS M
ROSENBERG A
RUTSTEIN J
SACK MR
SCHIFF MH
SINGLETON CM
TABORN J
TINDALL E
WEAVER AL
YOCUM D
Citation: Gv. Campion et al., DOSE-RANGE AND DOSE-FREQUENCY STUDY OF RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(7), 1996, pp. 1092-1101
Authors:
TUGWELL P
PINCUS T
YOCUM D
STEIN M
GLUCK O
KRAAG G
MCKENDRY R
TESSER J
BAKER P
WELLS G
Citation: P. Tugwell et al., COMBINATION THERAPY WITH CYCLOSPORINE AND METHOTREXATE IN SEVERE RHEUMATOID-ARTHRITIS, The New England journal of medicine, 333(3), 1995, pp. 137-141
Authors:
TUGWELL P
YOCUM D
PINCUS T
WELLS G
Citation: P. Tugwell et al., CYCLOSPORINE AND METHOTREXATE FOR SEVERE RHEUMATOID-ARTHRITIS - REPLY, The New England journal of medicine, 333(23), 1995, pp. 1568-1569
Authors:
KAINE J
SOLLINGER A
YOCUM D
LIPANI J
KLAS P
TESSER J
WIESENHUTTER C
OSULLIVAN F
SHUMAN S
RIGBY W
Citation: J. Kaine et al., RESULTS OF A MULTIDOSE PROTOCOL-7002 USING AN IMMUNOMODULATING, NON-DEPLETING PRIMATIZED(TM) ANTI-CD4 MONOCLONAL-ANTIBODY IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 38(9), 1995, pp. 195-195
Authors:
EISELE G
ADEWUNNI C
BAILIE GR
YOCUM D
VENEZIA R
Citation: G. Eisele et al., SURREPTITIOUS USE OF ANTIMICROBIAL AGENTS BY CAPD PATIENTS, Peritoneal dialysis international, 13(4), 1993, pp. 313-315
Authors:
COHEN S
RUTSTEIN J
LUGGEN M
SHERGY W
YOCUM D
SCHNITZER TJ
MARKENSON J
PINCUS T
BROOKS R
LISSE J
GERMAIN B
BENNETT R
WOLFE F
WEISMAN M
SONGCHAROEN S
Citation: S. Cohen et al., COMPARISON OF THE SAFETY AND EFFICACY OF CYCLOSPORINE-A AND METHOTREXATE IN REFRACTORY RHEUMATOID-ARTHRITIS - A RANDOMIZED, MULTI-CENTERED,PLACEBO-CONTROLLED TRIAL, Arthritis and rheumatism, 36(9), 1993, pp. 190000056-190000056
Risultati:
1-19
|